INFLUENZA A/B RAPID TEST DEVICE
Mexico·Clase I·III. DIAGNOSTIC AGENTS·DIINSEL, S.A. DE C.V.·Registered June 21, 2021INMUNOENSAYO IN VITRO PARA LADETECCIÓN DIRECTA Y CUALITATIVA DEANTIGENOS NUCLEOPROTEICOS VIRALES DEINFLUENZA A Y B DE HISOPOSNASALE/NASOFARINGEOS YLAVADOS/ASPIRADOS NASALES HUMANOS.
IN VITRO IMMUNOASSAY FOR THE DIRECT AND QUALITATIVE DETECTION OF INFLUENZA A AND B VIRAL NUCLEOPROTEIN ANTIGENS FROM HUMAN NASAL SWABS/NASOPHARYNXES AND NASAL WASHES/ASPIRATES.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- REACTIVODEDIAGNÓSTICOINVITROPARAINFLUENZA A/B
- Trade Name (English)
- REACTIVODEDIAGNÓSTICOINVITROPARAINFLUENZA A/B
- Analysis ID
- 1017R2021 SSA
- Registration Date
- June 21, 2021
- Name (Spanish)
- DIINSEL, S.A. DE C.V.
- Name (English)
- DIINSEL, S.A. DE C.V.
Access comprehensive regulatory information for INFLUENZA A/B RAPID TEST DEVICE (INFLUENZA A/B RAPID TEST DEVICE) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1017R2021 SSA and manufactured by DIINSEL, S.A. DE C.V.. The device was registered on June 21, 2021.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.